Second-line treatment for primary central nervous system lymphoma

Failure after first-line treatment was reported in 35–60% of immunocompetent patients with primary central nervous system lymphoma (PCNSL). There are currently no reports focusing on salvage therapy. This review analyses prognostic factors and the efficacy of salvage therapy by focusing on data from...

Descripción completa

Detalles Bibliográficos
Autores principales: Reni, M, Ferreri, A J M, Villa, E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362452/
https://www.ncbi.nlm.nih.gov/pubmed/10027325
http://dx.doi.org/10.1038/sj.bjc.6690083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362452/
https://www.ncbi.nlm.nih.gov/pubmed/10027325
http://dx.doi.org/10.1038/sj.bjc.6690083

Ejemplares similares